Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are among the
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …
Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline
GJ Criner, J Bourbeau, RL Diekemper, DR Ouellette… - Chest, 2015 - Elsevier
BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study
NR Anthonisen, JE Connett, JP Kiley, MD Altose… - Jama, 1994 - jamanetwork.com
Objective.—To determine whether a program incorporating smoking intervention and use of
an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 …
an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 …
Hospitalizations and mortality in the Lung Health Study
NR Anthonisen, JE Connett, PL Enright… - American journal of …, 2002 - atsjournals.org
This report deals with deaths and hospitalizations during the 5-year Lung Health Study, as
documented by examination of appropriate records. There were 149 deaths (2.5%) during …
documented by examination of appropriate records. There were 149 deaths (2.5%) during …
The problems of anticholinergic adverse effects in older patients
M Feinberg - Drugs & aging, 1993 - Springer
The old saying 'red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter'is
often quoted when describing the autonomic effects of drugs that block the muscarinic …
often quoted when describing the autonomic effects of drugs that block the muscarinic …
Contemporary management of chronic obstructive pulmonary disease: scientific review
Context The care of patients with chronic obstructive pulmonary disease (COPD) has
changed radically over the past 2 decades, and novel therapies can not only improve the …
changed radically over the past 2 decades, and novel therapies can not only improve the …
Pharmacoeconomic evaluation of COPD
DE Hilleman, N Dewan, M Malesker, M Friedman - Chest, 2000 - Elsevier
Study objectives The clinical outcomes and health-carecosts of a cohort of 413 patients with
COPD are reported. Design This study was a retrospective pharmacoeconomicanalysis …
COPD are reported. Design This study was a retrospective pharmacoeconomicanalysis …
Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit …
C Vogelmeier, R Buhl, CP Criée, A Gillissen… - …, 2007 - thieme-connect.com
Der folgende Text stellt eine Überarbeitung der Leitlinie der Deutschen Atemwegsliga und
der Deutschen Gesellschaft für Pneumologie von 2002 [1] dar. Diese ist notwendig …
der Deutschen Gesellschaft für Pneumologie von 2002 [1] dar. Diese ist notwendig …
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians
A Qaseem, V Snow, P Shekelle, K Sherif… - Annals of internal …, 2007 - acpjournals.org
Recommendation 1: In patients with respiratory symptoms, particularly dyspnea, spirometry
should be performed to diagnose airflow obstruction. Spirometry should not be used to …
should be performed to diagnose airflow obstruction. Spirometry should not be used to …
Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD
BC Moulton, AD Fryer - British journal of pharmacology, 2011 - Wiley Online Library
In the lungs, parasympathetic nerves provide the dominant control of airway smooth muscle
with release of acetylcholine onto M3 muscarinic receptors. Treatment of airway disease …
with release of acetylcholine onto M3 muscarinic receptors. Treatment of airway disease …